Clinical Trial

Characterization and Phenotyping of Patients Who Are Offered Drug Therapy for Obesity

Study acronym: DrugsOb1
Recruiting
View on ClinicalTrials.gov →
Summary
The study is multicenter and observational, consisting of a cross-sectional phase (V0) in which data will be collected from patients who are offered drug therapy, and a prospective longitudinal phase in which only patients who agree to start drug therapy for obesity will be involved
Trial Details
NCT Number NCT07414043
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Obesity & Overweight
Enrollment 500 participants
Start Date 2025-10-22
Primary Completion 2036-06-30 (estimated)
Study Completion 2036-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-17